FEATURED ARTICLES

• The Role Of Oncology Biomarkers In Personalizing Hematology Treatment Plans

  Oncology biomarkers guide personalized treatment and help track disease changes. Learn more about how advancements like liquid biopsies improve precision care.

• Making Informed Decisions In Your Oncology Study: Understanding Biomarkers

  Oncology biomarkers track tumor burden and reduce radiation from imaging. Composite algorithms improve response prediction. Fit-for-purpose strategies are needed to manage logistics and costs.

• Navigating The New Landscape Of Oncology Clinical Trials: A Strategic Imperative For Operations Teams

  The oncology landscape is growing but faces high screen-fail rates and trial complexity. To succeed, teams must move past traditional playbooks and adopt centralized pre-screening pipelines.

• Start Fast, Scale Seamlessly: Why A Different Oncology Model Was Needed

  Oncology programs don’t lose momentum because the science fails, but because execution fractures as complexity grows. Learn how continuity-first operating models help sponsors move faster.

• Keeping Oncology Programs Moving As Complexity Increases

  As oncology trials grow more complex, speed depends on clarity. Consistent oversight and shared data help teams make confident decisions faster without losing control.

• Scaling Oncology Trials Without Losing Momentum

  As oncology programs expand, complexity often replaces momentum. Explore how scaling introduces hidden operational challenges and why anticipating continuity early helps teams stay aligned.

• Why Early Phase Speed Depends On Oncology Expertise

  Early phase oncology speed depends on confident, oncology‑specific decisions made upfront. Learn why scientific expertise, realistic planning, and foresight determine whether programs maintain momentum.

• Unanticipated Roadblocks In Ovarian Cancer Drug Development

  Enhance your Ovarian cancer trials by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.

• Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier

  From the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.

• Early Phase Oncology Site Network: Benefits Of A Personal Touch

  Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.